In association with ophthalmic UV-A radiation, the solution is administered during conservative procedures for keratoconus and other corneal ectasia pathologies.
In particular the treatment is indicated in the following conditions:
- for all ectasic conditions of the cornea, whether genetic or iatrogenic
- for progressive keratoconus (clinically and instrumentally documented) and for diseases linked to wear of the cornea.
The treatment (UV-A + Riboflavin) helps to slow down the progression of keratoconus.
The treatment can prevent the necessity of corneal transplant.
The treatment does not exclude the possible need of keratoplasty in the future.
|